[Cardiovascular pharmacotherapy in old age]
Related Experiment Video
Updated: Jul 26, 2025

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
Published on: July 7, 2016
Martin Schulz1,2, Dietmar Trenk3, Ulrich Laufs4
1Institut für Pharmazie, Freie Universität Berlin, Berlin, Deutschland. m.schulz@fu-berlin.de.
Insights
Older adults with multiple conditions often require numerous medications. This review details pharmacotherapy for common cardiovascular diseases in elderly patients, addressing evidence gaps.
Area of Science:
- Geriatric Medicine
- Cardiology
- Clinical Pharmacology
Context:
- Cardiovascular diseases (CVDs) are leading causes of death and disability.
- Increasing prevalence of multimorbidity and polypharmacy in older populations.
- Limited clinical trial data on drug efficacy and safety in elderly patients with multiple conditions.
Purpose:
- To review pharmacotherapy options for hypertension, heart failure, and dyslipidemia in older adults.
- To discuss antithrombotic treatment strategies for elderly patients.
- To highlight challenges in managing polypharmacy in geriatric cardiovascular care.
Summary:
- Focuses on evidence-based pharmacotherapy for hypertension, chronic heart failure, and dyslipidemia in the elderly.
- Addresses antithrombotic therapy considerations for older individuals.
- Acknowledges limitations in clinical trial data for this demographic.
Impact:
- Aims to improve pharmacotherapeutic strategies for elderly patients with cardiovascular diseases and polypharmacy.
- Provides guidance for clinicians managing complex geriatric cardiovascular conditions.
- Contributes to optimizing treatment outcomes and patient safety in older adults with CVDs.
Abstract:
Cardiovascular diseases are the most frequent cause of disability and death. Evidence-based pharmacotherapy is the basis for successful treatment of common diseases, such as hypertension, heart failure, coronary artery disease, and atrial fibrillation. The proportion of older people with several diseases (multimorbidity) who need five or more drugs daily (polypharmacy) is steadily increasing. Evidence on the efficacy and safety of drugs in these patients is, however, limited because they are often excluded or underrepresented in clinical trials. In addition, clinical guidelines mostly focus on single diseases and only occasionally deal with the challenges in the pharmacotherapy of older multimorbid patients with polypharmacy. This article describes the options and special features of pharmacotherapy for hypertension, chronic heart failure and dyslipidemia, as well as antithrombotic treatment in (very) old people.
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiovascular Drugs: Classification based on Therapeutic Indications
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management

